JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.

Clinical trial NCT07154368 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07154368
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2025-09-23
Primary completion: 2027-10-31
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.